|
|
Medivir AB - Comparative Business Analysis Snapshot
Business Description
Medivir AB. The Group's principal activity is research and development of medicines. The Group conducts research and development in areas like labial herpes, hepatitis C, HIV, osteoporosis, osteoarthritis, skeletal metastases, chronic obstructive pulmonary disease (COPD) and high blood pressure. The Group had 89 patent families and 374 granted patents in force at the close of 2008. The Group operates in the United Kingdom and Sweden.
Competitor Analysis
This analysis compares Medivir AB with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
